Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HBM Healthcare InvestmentsXSWX:HBMNE -1.37%32 Return-on-Tangible-Asset is 46.10% as of Jun. 2026, which is 336% above its 10-year median of 10.57. GuruFocus rates XSWX:HBMNE with a GF Score™ of 32/100. The stock has 5 warning signs investors should review. Among 1,638 Asset Management companies, HBM Healthcare Investments ranks better than 95.12% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. HBM Healthcare Investments's annualizedNet Income for the quarter that ended in Jun. 2026 was CHF953.3 Mil. HBM Healthcare Investments's average total tangible assets for the quarter that ended in Jun. 2026 was CHF2,067.9 Mil. Therefore, HBM Healthcare Investments's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 46.10%.
The historical rank and industry rank for HBM Healthcare Investments's Return-on-Tangible-Asset or its related term are showing as below:
XSWX:HBMNE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -7.21 Med: 10.57 Max: 39.66
Current: 33.56
During the past 13 years, HBM Healthcare Investments's highest Return-on-Tangible-Asset was 39.66%. The lowest was -7.21%. And the median was 10.57%.
XSWX:HBMNE's Return-on-Tangible-Asset is ranked better than 95.12% of 1638
companies
in the Asset Management industry
Industry Median: 4.3
vs XSWX:HBMNE: 33.56
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
HBM Healthcare Investments Return-on-Tangible-Asset Related Terms
HBM Healthcare Investments Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:HBMNE vs BLK, BX, KKR: Return-on-Tangible-Asset Comparison
For the Asset Management subindustry, HBM Healthcare Investments's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HBM Healthcare Investments Return-on-Tangible-Asset vs Asset Management Industry
For the Asset Management industry and Financial Services sector, HBM Healthcare Investments's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where HBM Healthcare Investments's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 46.10% mean?
HBM Healthcare Investments (XSWX:HBMNE) has a Return-on-Tangible-Asset of 46.10% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HBM Healthcare Investments and its competitors. This is 336% above median its historical median of 10.57. According to the industry distribution chart, HBM Healthcare Investments ranks #80 out of 1638 companies in the Asset Management industry, placing it in the top 4.9%.
Is HBM Healthcare Investments' Return-on-Tangible-Asset too high?
HBM Healthcare Investments' current Return-on-Tangible-Asset of 46.10% is 336% above median its 10-year median of 10.57. The Asset Management industry median Return-on-Tangible-Asset is 4.30. HBM Healthcare Investments' value of 46.10% is 972.1% above this industry median. Based on the distribution chart, HBM Healthcare Investments ranks #80 out of 1638 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, HBM Healthcare Investments has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Return-on-Tangible-Asset compare to BLK and BX?
According to the Asset Management industry distribution chart, HBM Healthcare Investments ranks #80 out of 1638 companies for Return-on-Tangible-Asset. This places HBM Healthcare Investments in the top 5% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 4.30. HBM Healthcare Investments' value of 46.10% is 972.1% above this benchmark. While the company's 10-year median is 10.57 vs. the industry median of 4.30, HBM Healthcare Investments has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for an Asset Management company?
The median Return-on-Tangible-Asset among Asset Management companies is 4.30, based on 1,638 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HBM Healthcare Investments's current Return-on-Tangible-Asset of 46.10% is 972.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HBM Healthcare Investments and its competitors. For the Asset Management industry, the median Return-on-Tangible-Asset is 4.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HBM Healthcare Investments's current Return-on-Tangible-Asset is 46.10%, which is 336% above median its own 10-year median of 10.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (XSWX:HBMNE) has a current Return-on-Tangible-Asset of 46.10%. The current Return-on-Tangible-Asset is 46.10%, which is 336% above median its 10-year median of 10.57 and 972.1% above the Asset Management industry median of 4.30. HBM Healthcare Investments' overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For HBM Healthcare Investments (XSWX:HBMNE), the current Return-on-Tangible-Asset is 46.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
32GF Score
Get the complete analysis for XSWX:HBMNE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:HBMNE has been successfully added to your 
